Apyx Medical Expects FY2024 Sales Of $49.7M-$52.9M Versus Consensus Of $60.18M, With Net Loss Of $(26.5)M-$(24.3)M
Apyx Medical Expects FY2024 Sales Of $49.7M-$52.9M Versus Consensus Of $60.18M, With Net Loss Of $(26.5)M-$(24.3)M
Apyx Medical 預計 FY2024 的銷售額爲4,970萬至5,290萬美元,而市場預期爲6,018萬美元,淨虧損爲2650萬美元(2430萬美元)
- Total revenue guidance assumes:
- Advanced Energy revenue in the range of $41.6 million to $44.6 million, representing a decrease of approximately 4% to growth of approximately 3% year-over-year, compared to Advanced Energy revenue of $43.4 million for the year ended December 31, 2023.
- OEM revenue in the range of $8.1 million to $8.3 million, representing a decrease of 10% to 7% year-over-year, compared to $9.0 million for the year ended December 31, 2023.
- 總收入指導假設:
- 先進能源收入在4,160萬美元至4,460萬美元之間,同比下降約4%,同比增長約3%,而截至2023年12月31日的年度先進能源收入爲4,340萬美元。
- 原始設備製造商收入在810萬美元至830萬美元之間,與截至2023年12月31日止年度的900萬美元相比,同比下降10%至7%。